US Pharmaceuticals and Biotechnology Industry Comparative Analysis and Companies Ranking

Date: July 15, 2014
Pages: 50
Price:
US$ 1,000.00
Publisher: BAC Reports
Report type: Strategic Report
Delivery: E-mail Delivery - PDF (on default), Hard Copy Mail Delivery (+US$ 140.00)
ID: U3CD58DCA4EEN
Leaflet:

Download PDF Leaflet

US Pharmaceuticals and Biotechnology Industry Comparative Analysis and Companies Ranking
  • The report analyses Pharmaceuticals and Biotechnology Industry in US. It covers general statistics, including industry volumes by sales and income, and industry dynamics within the recent period. The description of industry structure by company is included as well, establishing extent of market concentration and evaluating companies’ market shares. Analysis includes detailed information about the internal and external factors that affect Pharmaceuticals and Biotechnology Industry in US.
  • The report provides detailed Pharmaceuticals and Biotechnology Industry comparative analysis with interrelated data on major companies. The areas under consideration are as follows:
    - company strategic position in the industry
    - profitability and margin analysis
    - assets turnover and credit ratios reviews
    - long-term solvency indicators
    - growth trends comparison
  • The report also presents company rankings by size, value, profit margin and growth history, thus giving a full picture of each company mentioned.
  • The report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases. Annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of the industry.

RESEARCH METHODOLOGY

DISCLAIMER

1. CORPORATE ANALYSIS OF US PHARMACEUTICALS AND BIOTECHNOLOGY INDUSTRY

1.1. Key Facts
1.2. Industry Volume
1.3. Industry Dynamics

2. US PHARMACEUTICALS AND BIOTECHNOLOGY INDUSTRY COMPARATIVE ANALYSIS

2.1. Stock Analysis
2.2. Current Market State
2.3. Comparative Financial Analysis
  2.3.1. Profitability Analysis
  2.3.2. Margin Analysis
  2.3.3. Assets Turnover Analysis
  2.3.4. Credit Ratios
  2.3.5. Long-Term Solvency Analysis
  2.3.6. Growth Over Prior Year Trends

3. US PHARMACEUTICALS AND BIOTECHNOLOGY INDUSTRY RANKINGS

3.1. Company Rankings by Size
3.2. Company Rankings by Value
3.3. Company Rankings by Profit Margins
3.4. Company Rankings by Growth History

4. US PHARMACEUTICALS AND BIOTECHNOLOGY INDUSTRY NEWS

4.1. News & PR Activity Analysis
4.2. US Pharmaceuticals and Biotechnology Industry Significant Developments
4.3. Marketing News
4.4. Corporate Events

5. INDUSTRY EXPERTS FORECAST AND OPINIONS

APPENDIX: RATIO DEFINITIONS


LIST OF TABLES

Table 1. The list of Companies Included in the Research
Table 2. US Pharmaceuticals and Biotechnology Industry Snapshot
Table 3. US Pharmaceuticals and Biotechnology Industry Annual Revenues, Gross Profit and Net Income, 2009-2012
Table 4. US Pharmaceuticals and Biotechnology Industry Quarterly Revenues, Gross Profit and Net Income
Table 5. US Pharmaceuticals and Biotechnology Industry Annual Growth Rates, %
Table 6. US Pharmaceuticals and Biotechnology Industry Quarterly Growth Rates, %
Table 7. US Pharmaceuticals and Biotechnology Industry Companies Stock Performance
Table 8. Companies Market Shares in 2009-2012, %
Table 9. US Pharmaceuticals and Biotechnology Industry Companies Profitability Ratios
Table 10. US Pharmaceuticals and Biotechnology Industry Companies Margin Analysis Ratios
Table 11. US Pharmaceuticals and Biotechnology Industry Companies Assets Turnover Ratios
Table 12. US Pharmaceuticals and Biotechnology Industry Companies Credit Ratios
Table 13. US Pharmaceuticals and Biotechnology Industry Companies Long-Term Solvency Ratios
Table 14. US Pharmaceuticals and Biotechnology Industry Companies Growth Over Prior Year Ratios
Table 15. US Pharmaceuticals and Biotechnology Industry Leaders by Market Capitalization
Table 16. US Pharmaceuticals and Biotechnology Industry Leaders by Revenues
Table 17. US Pharmaceuticals and Biotechnology Industry Leaders by Net Income
Table 18. US Pharmaceuticals and Biotechnology Industry Leaders by Employees
Table 19. US Pharmaceuticals and Biotechnology Industry Leaders by Price per Earnings
Table 20. US Pharmaceuticals and Biotechnology Industry Leaders by Price to Sales
Table 21. US Pharmaceuticals and Biotechnology Industry Leaders by Price to Book
Table 22. US Pharmaceuticals and Biotechnology Industry Leaders by Price to Cash Flow
Table 23. US Pharmaceuticals and Biotechnology Industry Leaders by Profit Margin
Table 24. US Pharmaceuticals and Biotechnology Industry Leaders by Operating Margin
Table 25. US Pharmaceuticals and Biotechnology Industry Leaders by Return on Assets
Table 26. US Pharmaceuticals and Biotechnology Industry Leaders by Earnings per Share
Table 27. US Pharmaceuticals and Biotechnology Industry Leaders by Revenue Growth Rate


LIST OF FIGURES

Figure 1. US Pharmaceuticals and Biotechnology Industry Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Figure 2. Industry Concentration in 2012, %
Figure 3. US Pharmaceuticals and Biotechnology Industry Dynamics, 4 Year Trends
Figure 4. US Pharmaceuticals and Biotechnology Industry Dynamics, Last 4 Quarter Trends
Figure 5. US Pharmaceuticals and Biotechnology Industry 1-year Stock Chart
Figure 6. US Pharmaceuticals and Biotechnology Industry 5-year Stock Chart
Figure 7. US Pharmaceuticals and Biotechnology Industry vs. Main Indexes 1-year Stock Chart
Figure 8. US Pharmaceuticals and Biotechnology Industry Structure by Companies, %
Figure 9. Growth-Share Matrix: Companies Strategic Position in US Pharmaceuticals and Biotechnology Industry (Recent Year Trends)
Figure 10. Growth-Share Matrix: Companies Strategic Position in US Pharmaceuticals and Biotechnology Industry (Recent Quarter Trends)
Figure 11. Return on Assets Chart by Companies in 2009-2012
Figure 12. Return on Equity Chart by Companies in 2009-2012
Figure 13. Profitability Peer Analysis
Figure 14. Profit Margin Chart by Companies in 2009-2012
Figure 15. Operating Margin Chart by Companies in 2009-2012
Figure 16. Margin Peer Analysis
Figure 17. Assets Turnover Peer Analysis
Figure 18. Current Ratio Chart by Companies in 2009-2012
Figure 19. Growth Over Prior Year Peer Analysis
Figure 20. US Pharmaceuticals and Biotechnology Industry Article Density Chart


THE FOLLOWING COMPANIES ARE INCLUDED IN THE RESEARCH:

Pacific Biosciences of California, Inc.Pacifichealth Laboratories Inc.Pain Therapeutics Inc.
Palatin Technologies Inc.Par Pharmaceutical Companies Inc.Parexel International Corp.
PDL BioPharma, Inc.Peregrine Pharmaceuticals Inc.PerkinElmer Inc.
Pernix Therapeutics Holdings, Inc.Perrigo Co.Pfizer Inc.
Pharma-Bio Serv, Inc.Pharmaceutical Product Development Inc.Pharmacyclics Inc.
Pharmasset, Inc.PharmAthene, Inc.Pharmos Corp.
PhytoMedical Technologies Inc.PolyMedix, Inc.Poniard Pharmaceuticals, Inc.
Power 3 Medical Products Inc.PowerVerde, Inc.POZEN, Inc.
Precision Optics Corp. Inc.Pressure BioSciences, Inc.Pro-Pharmaceuticals Inc.
Progenics Pharmaceuticals Inc.ProPhase Labs, Inc.Protalex Inc.
Proteo Inc.Proteonomix, Inc.Provectus Pharmaceuticals, Inc.
pSivida Corp.Pulmo BioTech Inc.Puramed Bioscience Inc
Pure BiosciencePuriCore plc.Questcor Pharmaceuticals, Inc.
Quick-Med Technologies Inc.Radient Pharmaceuticals CorporationRaptor Pharmaceuticals Corp.
Redpoint Bio CorporationReflect Scientific, Inc.Regeneron Pharmaceuticals, Inc.
Regenerx Biopharmaceuticals Inc.Regenicin, Inc.Repligen Corporation
Repros Therapeutics Inc.Response Genetics, IncRexahn Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc.RXi Pharmaceuticals CorporationSalix Pharmaceuticals Ltd.
Sangamo Biosciences Inc.Sanguine Corp.Santarus Inc.
Savient Pharmaceuticals, Inc.SciClone Pharmaceuticals, Inc.SCOLR Pharma Inc.
Seattle Genetics Inc.Senesco Technologies Inc.SensiVida Medical Technologies, Inc.
Sequenom Inc.SeraCare Life Sciences, Inc.SIGA Technologies, Inc.
Soligenix, Inc.Somaxon Pharmaceuticals, Inc.Sorrento Therapeutics, Inc.
Spectrum Pharmaceuticals, Inc.Stellar Biotechnologies, Inc.Stem Cell Authority, Ltd.
StemCells Inc.Strategic Diagnostics Inc.Sucampo Pharmaceuticals, Inc.
Sunesis Pharmaceuticals Inc.SuperGen Inc.Symbollon Pharmaceuticals Inc.
Synergy Pharmaceuticals, Inc.Synta Pharmaceuticals Corp.SyntheMed Inc.
Talon Therapeutics, Inc.Tamir Biotechnology, Inc.TapImmune, Inc.
Targacept, Inc.Targeted Genetics Corp.Techne Corp.
Telik Inc.Tengion, Inc.TheraBiogen Inc.
and 359 companies more

The above Industry Comparative Analysis is a half-ready report.
It only requires updating with the help of new data that are constantly retrieved from Publisher’s databases and other sources. This updating process takes 3-5 business days after order is placed. Thus, our clients always obtain a revised and updated version of each report. Please also note that we do not charge for such an updating procedure. Business Analytic Center (BAC) has information for more than 40,000 different companies available but it is impossible to have all reports updated immediately. That is why it takes 3-5 days to update a report after an order is received.

LIST OF TABLES



Table 1. The list of Companies Included in the Research

Table 2. US Pharmaceuticals and Biotechnology Industry Snapshot

Table 3. US Pharmaceuticals and Biotechnology Industry Annual Revenues, Gross Profit and Net Income, 2009-2012

Table 4. US Pharmaceuticals and Biotechnology Industry Quarterly Revenues, Gross Profit and Net Income

Table 5. US Pharmaceuticals and Biotechnology Industry Annual Growth Rates, %

Table 6. US Pharmaceuticals and Biotechnology Industry Quarterly Growth Rates, %

Table 7. US Pharmaceuticals and Biotechnology Industry Companies Stock Performance

Table 8. Companies Market Shares in 2009-2012, %

Table 9. US Pharmaceuticals and Biotechnology Industry Companies Profitability Ratios

Table 10. US Pharmaceuticals and Biotechnology Industry Companies Margin Analysis Ratios

Table 11. US Pharmaceuticals and Biotechnology Industry Companies Assets Turnover Ratios

Table 12. US Pharmaceuticals and Biotechnology Industry Companies Credit Ratios

Table 13. US Pharmaceuticals and Biotechnology Industry Companies Long-Term Solvency Ratios

Table 14. US Pharmaceuticals and Biotechnology Industry Companies Growth Over Prior Year Ratios

Table 15. US Pharmaceuticals and Biotechnology Industry Leaders by Market Capitalization

Table 16. US Pharmaceuticals and Biotechnology Industry Leaders by Revenues

Table 17. US Pharmaceuticals and Biotechnology Industry Leaders by Net Income

Table 18. US Pharmaceuticals and Biotechnology Industry Leaders by Employees

Table 19. US Pharmaceuticals and Biotechnology Industry Leaders by Price per Earnings

Table 20. US Pharmaceuticals and Biotechnology Industry Leaders by Price to Sales

Table 21. US Pharmaceuticals and Biotechnology Industry Leaders by Price to Book

Table 22. US Pharmaceuticals and Biotechnology Industry Leaders by Price to Cash Flow

Table 23. US Pharmaceuticals and Biotechnology Industry Leaders by Profit Margin

Table 24. US Pharmaceuticals and Biotechnology Industry Leaders by Operating Margin

Table 25. US Pharmaceuticals and Biotechnology Industry Leaders by Return on Assets

Table 26. US Pharmaceuticals and Biotechnology Industry Leaders by Earnings per Share

Table 27. US Pharmaceuticals and Biotechnology Industry Leaders by Revenue Growth Rate




LIST OF FIGURES



Figure 1. US Pharmaceuticals and Biotechnology Industry Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit

Figure 2. Industry Concentration in 2012, %

Figure 3. US Pharmaceuticals and Biotechnology Industry Dynamics, 4 Year Trends

Figure 4. US Pharmaceuticals and Biotechnology Industry Dynamics, Last 4 Quarter Trends

Figure 5. US Pharmaceuticals and Biotechnology Industry 1-year Stock Chart

Figure 6. US Pharmaceuticals and Biotechnology Industry 5-year Stock Chart

Figure 7. US Pharmaceuticals and Biotechnology Industry vs. Main Indexes 1-year Stock Chart

Figure 8. US Pharmaceuticals and Biotechnology Industry Structure by Companies, %

Figure 9. Growth-Share Matrix: Companies Strategic Position in US Pharmaceuticals and Biotechnology Industry (Recent Year Trends)

Figure 10. Growth-Share Matrix: Companies Strategic Position in US Pharmaceuticals and Biotechnology Industry (Recent Quarter Trends)

Figure 11. Return on Assets Chart by Companies in 2009-2012

Figure 12. Return on Equity Chart by Companies in 2009-2012

Figure 13. Profitability Peer Analysis

Figure 14. Profit Margin Chart by Companies in 2009-2012

Figure 15. Operating Margin Chart by Companies in 2009-2012

Figure 16. Margin Peer Analysis

Figure 17. Assets Turnover Peer Analysis

Figure 18. Current Ratio Chart by Companies in 2009-2012

Figure 19. Growth Over Prior Year Peer Analysis

Figure 20. US Pharmaceuticals and Biotechnology Industry Article Density Chart





THE FOLLOWING COMPANIES ARE INCLUDED IN THE RESEARCH:


Pacific Biosciences of California, Inc.Pacifichealth Laboratories Inc.Pain Therapeutics Inc.
Palatin Technologies Inc.Par Pharmaceutical Companies Inc.Parexel International Corp.
PDL BioPharma, Inc.Peregrine Pharmaceuticals Inc.PerkinElmer Inc.
Pernix Therapeutics Holdings, Inc.Perrigo Co.Pfizer Inc.
Pharma-Bio Serv, Inc.Pharmaceutical Product Development Inc.Pharmacyclics Inc.
Pharmasset, Inc.PharmAthene, Inc.Pharmos Corp.
PhytoMedical Technologies Inc.PolyMedix, Inc.Poniard Pharmaceuticals, Inc.
Power 3 Medical Products Inc.PowerVerde, Inc.POZEN, Inc.
Precision Optics Corp. Inc.Pressure BioSciences, Inc.Pro-Pharmaceuticals Inc.
Progenics Pharmaceuticals Inc.ProPhase Labs, Inc.Protalex Inc.
Proteo Inc.Proteonomix, Inc.Provectus Pharmaceuticals, Inc.
pSivida Corp.Pulmo BioTech Inc.Puramed Bioscience Inc
Pure BiosciencePuriCore plc.Questcor Pharmaceuticals, Inc.
Quick-Med Technologies Inc.Radient Pharmaceuticals CorporationRaptor Pharmaceuticals Corp.
Redpoint Bio CorporationReflect Scientific, Inc.Regeneron Pharmaceuticals, Inc.
Regenerx Biopharmaceuticals Inc.Regenicin, Inc.Repligen Corporation
Repros Therapeutics Inc.Response Genetics, IncRexahn Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc.RXi Pharmaceuticals CorporationSalix Pharmaceuticals Ltd.
Sangamo Biosciences Inc.Sanguine Corp.Santarus Inc.
Savient Pharmaceuticals, Inc.SciClone Pharmaceuticals, Inc.SCOLR Pharma Inc.
Seattle Genetics Inc.Senesco Technologies Inc.SensiVida Medical Technologies, Inc.
Sequenom Inc.SeraCare Life Sciences, Inc.SIGA Technologies, Inc.
Soligenix, Inc.Somaxon Pharmaceuticals, Inc.Sorrento Therapeutics, Inc.
Spectrum Pharmaceuticals, Inc.Stellar Biotechnologies, Inc.Stem Cell Authority, Ltd.
StemCells Inc.Strategic Diagnostics Inc.Sucampo Pharmaceuticals, Inc.
Sunesis Pharmaceuticals Inc.SuperGen Inc.Symbollon Pharmaceuticals Inc.
Synergy Pharmaceuticals, Inc.Synta Pharmaceuticals Corp.SyntheMed Inc.
Talon Therapeutics, Inc.Tamir Biotechnology, Inc.TapImmune, Inc.
Targacept, Inc.Targeted Genetics Corp.Techne Corp.
Telik Inc.Tengion, Inc.TheraBiogen Inc.
and 359 companies more



Ask Your Question

US Pharmaceuticals and Biotechnology Industry Comparative Analysis and Companies Ranking
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: